TH and Parkinson disease: Ceftriaxone reportedly reduced the loss of dopaminergic neurons in PD patients by increasing GLT-1 expression [23], and our results also confirmed that ceftriaxone could increase TH and GLT-1 expression in mouse substantia nigra.